Jubilant Ingrevia Pegged for FY27 Turnaround on CDMO Scale-Up and Operating Leverage

An unnamed brokerage flags FY27 as an inflection year for Jubilant Ingrevia, citing CDMO ramp-up, better nutrition mix, and fixed-cost absorption from newly commissioned assets.

ndtv-profit-business · 7/3/2026, 4:17:48 AM · Ask about this →